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Spinal anesthesiaAbstract Objective: The aim of this study was to evaluate the efﬁcacy of prophylactic pregabalin
on postdural puncture headache incidence and severity after spinal anesthesia.
Method: 86 ASA I-II male and female patients age 20–50 years old, undergoing elective general
surgeries below the umbilicus under spinal anesthesia with 3 ml heavy bupivacaine 0.5% (15 mg),
patients were randomly allocated into one of two groups (Group C, n= 43) (control group)
received a placebo capsule 2 h preoperatively (Group P, n= 43) received 150 mg pregabalin capsule
2 h preoperatively, number of attempts for spinal block, sensory level, motor block grade, postop-
erative time to ﬁrst analgesic requirement, the incidence, onset and intensity of PDPH and adverse
events were recorded for 72 h.
Results: The peak sensory level in C group and P group showed no statistical signiﬁcant difference,
the time to peak sensory block was signiﬁcantly earlier in P group than group C, the time to reach
the modiﬁed Bromage motor block grade 3 was signiﬁcantly earlier in P group than C group, time
to two segment regression of sensory level to S1 and motor block regression to modiﬁed Bromage
grade 0 were statistically insigniﬁcant between the studied groups. Group P had a signiﬁcantly
longer time to ﬁrst analgesic requirements than group C, and there was no signiﬁcant difference
in VAS (visual analogue scale) of pain between the studied groups. There was signiﬁcant increase
358 G.E. Rahmawy et al.in sedation score in P group compared to C group at 2 h and 6 h postoperatively, and there was
statistically signiﬁcant reduction in the incidence rate and severity of PDPH in P group compared
to group C. There were no recorded cases of dizziness, visual disturbances, or PONV.
Conclusions: preoperative oral pregabalin 150 mg reduced the incidence and severity of PDPH,
beside the earlier onset of peak sensory and motor block with increase duration of analgesia in
patients undergoing elective surgeries under spinal anesthesia.
ª 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.
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Postdural puncture headache (PDPH) is unpleasant complica-
tion following dural puncture. The incidence of PDPH follow-
ing dural puncture ranges from 0.3% to 20% in spinal
anesthesia and up to 70% after accidental dural puncture in
epidural anesthesia [1]. The incidence rate of PDPH is related
to age, gender, needle size, pregnancy, and a previous history
of PDPH [2]. PDPH is characterized by severe, dull nonthrob-
ing pain, often fronto-occipital, aggravated by erect or sitting
position coughing, sneezing or straining, and diminished in su-
pine position. It may be associated with nausea, vomiting, or
visual disturbances [3]. Headache starts one or 2 days after
spinal anesthesia and if left untreated, relieved spontaneously
after a week [3,4].
The real etiology of PDPH is not fully understood, but
mostly the decreased CSF volume as a result of CSF leakage
leading to reduced pressure and cerebral venodilation [1,5,6].
Pregabalin is an antiepileptic drug, it is a structural ana-
logue of gamma-aminobutyric acid (GABA), and it is effective
in reducing hyperalgesia in pain model and may play an
important role in acute postoperative pain in humans [7].
It was reported that pregabalin may be useful for the man-
agement of PDPH in patients who developed PDPH after
spinal anesthesia or diagnostic and/or therapeutic lumbar
puncture [8].
To our knowledge, there is no study used pregabalin as a
prophylaxis agent against PDPH. This study was designed to
evaluate the efﬁcacy of prophylactic pregabalin on postdural
puncture headache incidence and severity after spinal
anesthesia.
2. Patients and method
After approval of the ethical committee, a written informed
consent was obtained, this double blind study was conducted
on 86 patients of both sex, ASA I&II aged 20–50 years old,
planned for elective general surgeries below the umbilicus (re-
pair of inguinal hernia, varicocele, and varicose vein) under
spinal anesthesia at El – Mansoura Main University Hospital
from January 2012 to July 2012. Patients were excluded from
the study if they had history convulsions, diabetes, those with
known allergy to amide local anesthetic or to the study drugs,
or any contraindication to regional anesthesia (e.g., local infec-
tion, coagulation abnormality, tight valvular heart lesion, or
patient refusal), patients with psychological, spinal cord defor-
mity, previous spinal surgery, and pregnant and patients with
chronic headache were also excluded. The study protocol was
explained to each patient during the preoperative visit. No pre-
medication was given to the patients. In the operating room,
18 G intravenous cannula was inserted and IV normal salineat a rate of 10 ml kg1 was started. Intraoperative monitoring
every 10 min includes the following: Electrocardiogram, pulse
oximetry, and noninvasive arterial blood pressure. The pa-
tients were randomly divided to one of two groups using closed
envelope technique for randomization, to maintain the blind
nature of the study, the studied drug were given by a well
trained anesthesia resident (unaware of the study drugs)
according to the instructions written in a sealed envelope
and were given to the patients in the ward as follows: Group
C (control group) (n= 43): received a placebo capsule 2 h pre-
operatively. Group P (n= 43): received 150 mg pregabalin
capsule (vronogabic) 150 mg pregabalin capsule 2 h preopera-
tively. Spinal anesthesia was performed under strict aseptic
technique in the sitting position, 2 ml lidocaine 2% for local
inﬁltration of the skin at L3–L4 or L4–L5 space, then insertion
of 25-G Quincke type spinal needle by midline approach, when
free ﬂow of CSF was obtained, a 3 ml heavy bupivacaine 0.5%
(15 mg) was injected, spinal needle was withdrawn, and the pa-
tients were put in the supine position immediately, supple-
mented with oxygen 3 l/min by face mask.
At the end of surgery, patient was transferred to PACU
where they were monitored and received supplemental oxygen
(4 l min1) by facemask for 1 h; then, they were shifted to the
wards.
The following parameters were evaluated and recorded by
an anesthesiologist unaware of the study drugs: Patient charac-
teristics, number of attempts to perform spinal anesthesia, and
sensory level were assessed by pin prick 5 min after completion
of spinal anesthesia. Motor block was evaluated by the modi-
ﬁed Bromage motor scale (Grade 0: No motor block, Grade 1
Inability to raise extended leg; able to move knees and feet,
Grade 2: Inability to raise extended leg and move knee; able
to move feet, Grade 3: Complete motor block of limb) 5 min
after the completion of spinal anesthesia, time to peak sensory
block and to two segment regression (minutes), onset time to
modiﬁed Bromage 3 and time of regression to modiﬁed Bro-
mage 0 (minutes).
The postoperative pain at rest was assessed using VAS
(visual analogue scale), where zero score corresponds to no
pain and 10 to the maximum or worst pain, if VASSP 4,
75 mg diclofenac sodium intramuscular/12 h was planned to
be given. The onset, incidence, and severity of PDPH in 72 h
were recorded, time to rescue analgesia in minutes. The inten-
sity of the headache was assessed according to a previous study
[9]: Class I: Patient suffers from a mild headache while sitting
or walking, Class II: Patient suffers from a moderate to severe
headache while sitting or walking, Class III: Patient suffers
from a moderate to severe headache even in supine position
which impedes his/her daily activities. Sedation was assessed
by Ramsy et al. sedation score [10] and other complications
such as dizziness, nausea, and vomiting visual disturbances
were recorded. If any patient complained from PDPH, bed
Table 1 Demographic characteristics of patients in the study
groups. Data were expressed as mean ± SD and numbers.
Group (C n= 43) Group (P n= 43)
Age (year) 29.6 ± 6.5 28 ± 6.8
Weight (kg) 75.4 ± 7.9 77.1 ± 7.4
Sex (male/female) 25/18 27/16
Height (cm) 170.1 ± 10.2 167.8 ± 8.4
Duration of surgery (min) 145.2 ± 2.6 139.6 ± 7.6
Group (C): control group.
Group (P): pregabalin group. Figure 1 Postoperative VAS of pain in the studied groups
Group (C):control group, Group (P): pregabalin group.
Postdural puncture headache 359rest, hydration was tried, and if the PDPH was not relieved,
oral paracetamol 500 mg with caffeine 65 mg (panadol extra,
Galaxo Smith)/8 h was planned to be given.
3. Statistical analysis
Sample size was calculated by using one tail z test in G \power
3.1.5 program. According to a pilot study (10 patients in each
group), we calculated that 43 patients per each group were suf-
ﬁcient to give p< 0.05 signiﬁcant with conﬁdence interval
95% with a actual power of 95% when incidence rate of
PDPH in placebo group was (4) and in pregabalin group
was (1). Statistical analyses were performed using SPSS 16
(SPSS Inc., Chicago, IL, USA). Parametric data were analyzed
using the independent t-test. Nonparametric data were com-
pared using Mann–Whitney test. Chi-square test was used
for comparison between percentages and frequencies. All val-
ues were expressed as mean (SD), number or percentage (%)
of patient. Signiﬁcance level was established at a p
value 6 0.05.
4. Results
Eighty-six patients were enrolled and completed; this study
had statistically insigniﬁcant differences among patients demo-
graphic (age, sex, and weight) and duration of surgery (Ta-
ble 1). The peak sensory level reached was T6 (T6–T8) in (C)
group, T7 (T5–T8) in (P) group without any statistical differ-
ence between the groups, but the time to peak sensory block
was signiﬁcantly earlier in (P) group than group (C)
(p= 0.05) (Table 2). All patients achieved modiﬁed Bromage
motor block grade 3 which was signiﬁcantly earlier in (P)Table 2 Spinal block characteristics (onset and regression time of
mean ± SD.
Group (C n=
Peak sensory block level T6(6–8)
Time to Peak sensory block (min) 10.8 ± 1.7
Time to two segment regression (min) 72.2 ± 7.1
Onset time to modiﬁed Bromage 3 (min) 13.6 ± 2.4
Regression to modiﬁed Bromage 0 (min) 144.6 ± 14.2
Time to rescue analgesia (min) 225.6 ± 35.1
Group (C): control group.
Group (P): pregabalin group.
p 6 0.05 Statistically signiﬁcance.group than (C) group (p= 0.02), Time to two segment regres-
sion, sensory level regression to S1 and motor block regression
to modiﬁed Bromage motor block grade 0 were statistically
insigniﬁcant among the studied groups (Table 2). Group (P)
had a signiﬁcantly longer time to ﬁrst analgesic requirement
than group (C) (p= 0.04) (Table 2), and there was no signiﬁ-
cant difference in VAS of pain between studied groups (Fig. 1).
There was signiﬁcant increase in sedation score in (P) group
compared with (C) group at 2 h and 6 h postoperatively
(p 6 0.001). There was statistically signiﬁcant reduction in
the incidence rate of PDPH in (P) group 7(16%) compared
with group (C) 13(30%) (p= 0.02) with signiﬁcant reduction
in the intensity of PDPH; in group (P), one patient (14%)
had class III PDPH compared to group (C) in which six pa-
tients (46%) had class III PDPH (p= 0.008), and there was
no signiﬁcant differences between the studied groups as regard
the number of needle attempts (Table 3). Four patients had
Class I PDPH in Group P and 3 in Group C relived with
bed rest, good hydration, and patients who had Class II and
III PDPH received oral paracetamol 500 mg with caffeine
65 mg (panadol extra, Galaxo Smith)/8 h.
There were no recorded cases of dizziness or postoperative
nausea and vomiting or visual disturbances (see Fig. 2).
5. Discussion
The results of the present study showed that prophylactic oral
pregabalin 150 mg 2 h before surgery was effective in reduction
in the incidence and severity of postdural puncture headache,
with earlier onset of peak sensory and motor block with in-
crease duration of analgesia compared to a placebo in patients
undergoing elective surgeries under spinal anesthesia, this maysensory and motor blocks in minutes). Data were expressed as
43) Group (P n= 43) p Value
T7(5–8)
7.6 ± 1.2 0.05
74.3 ± 1.4
11.4 ± 2.8 0.02
150.1 ± 15.8
248.6 ± 57.8 0.04
Figure 2 Postoperative sedation score in the studied groups
Group (C): control group, Group (P): pregabalin group.
Table 3 PDPH characters (incidence rate, intensity classes, time of onset (day), and number of needle attempts). Data were expressed
in number with or without (%).
Group (C n= 43) Group (P n= 43) p Value
Incidence of headache 13(30%) 7(16%) 0.02
Classes of headache
Class I 3(23%) 4(57%)
Class II 4(31%) 2(29%)
Class III 6(46%) 1(14%) 0.008
Onset day of headache
Fist day 0 0
Second day 9 5
Third day 4 2
Number of spinal needle punctures
One attempt 37 35
Two attempts 6 8
Group (C): control group.
Group (P): pregabalin group.
p 6 0.05 statistically signiﬁcance.
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gesic, and anxiolytic [11,12], the main mechanism of action
pregablin is through blocking the development of hyperalgesia
and central sensitization, and it binds to the a2-d_ subunit of
voltage-gated calcium channels with binding afﬁnity six times
more than that of gabapentin, reducing the release of excit-
atory neurotransmitters including glutamate, noradrenaline,
serotonin, dopamine, and substance P. Additionally, it also
produces an inhibitory modulation of neuronal excitability in
areas of the central nervous system dense in synaptic connec-
tions as the neocortex, amygdala, and hippocampus [12–14].
Zencirci [7] reported that oral pregabalin 150 mg/day reduced
the severity of postdural puncture headache in two females
who did not respond to conventional treatments with oral par-
acetamol and caffeine (300 mg/day), bed rest and hydration
and 200 mg intravenous theophylline infusion for 36 h with
no recorded side effects except sedation. Huseyinoglu and
coworkers [8] found that oral pregabalin was effective in treat-
ment of PDPH after spinal anesthesia or diagnostic and/or
therapeutic lumbar puncture, patients were given 150 mg/day
oral pregabalin for the ﬁrst 3 days, and then, 300 mg/day for
further 2 days had signiﬁcantly lower visual analog scale scores
after the second day of treatment. In the same line of our re-
sults, Ghai et al. [15] documented that single dose of 300 mg
pregabalin 1–2 h prior to abdominal hysterectomy associated
with increased the time to ﬁrst request for analgesia. More-over, another study showed that oral premedication with pre-
gabalin 150 and 300 mg reduced analgesic consumption in
laparoscopic hysterectomy [16].
6. Conclusion
Preoperative oral pregabalin 150 mg reduced the incidence and
severity of PDPH, beside the earlier onset of peak sensory and
motor block with increase duration of analgesia in patients
undergoing elective surgeries under spinal anesthesia.
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